Pain Brake
Washington University School of Medicine researchers discovered that μ-opioid receptors (MORs)on neurons in the brain's locus coeruleus act as a biological brake on chronic neuropathic pain — published August 17 in Current Biology. Mice lacking these receptors became hypersensitive to touch and heat; restoring them reversed the pain entirely. The goal: targeted LC-specific therapies that deliver relief without systemic opioid side effects.
Why this matters: Current opioid drugs act broadly across the brain and body, causing addiction, sedation, and respiratory depression. The locus coeruleus MOR brake is anatomically specific — targeted delivery to LC-resident MORs could interrupt the chronic pain loop without engaging reward circuits or peripheral opioid receptors.
The LC sends noradrenergic projections down to the dorsal horn of the spinal cord, modulating how incoming pain signals are gated. Without MOR brakes, the LC fires in a sustained high-activity state that amplifies central sensitization — the same mechanism underlying fibromyalgia and phantom limb pain.